Novabay Pharmaceuticals, Inc.
NBY
Revenue
6.32M
▲2.23M▲54.39%
3 Months ChangeAssets
3.93M
▼-1.43M▼-26.73%
3 Months ChangeLiabilities
4.54M
▼-655.00k▼-12.60%
3 Months ChangeFree Cash Flow
-1.57M
▼-374.00k▼-31.17%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001437749-24-032365
2024-10-16
Form 8-K
ID: 0001437749-24-031362
2024-09-20
Form 8-K
ID: 0001437749-24-029642
2024-08-13
Form 10-Q
ID: 0001437749-24-026386
2024-07-29
Form 8-K
ID: 0001437749-24-023740
2024-07-11
Form 8-K
ID: 0001437749-24-022526
2024-06-14
Form 8-K
ID: 0001437749-24-020277
2024-06-07
Form 8-K
ID: 0001437749-24-019536
2024-05-31
Form 8-K
ID: 0001437749-24-018930
2024-05-29
Form 8-K
ID: 0001437749-24-018612